MLK3, the downstream kinase of the MAP4K1 pathway, predicts poor prognosis in patients with IDH-wt gliomas and regulates cytoskeleton remodeling of GBM cells by directly binding EPS8 (Zhu et al, 2020). The gene discussed is IDH2; the disease is glioma.